Literature DB >> 17080247

Sleep-related autonomic disturbances in symptom subgroups of women with irritable bowel syndrome.

Jennifer J T Robert1, Sigrid Elsenbruch, William C Orr.   

Abstract

The objective was to investigate whether predominant symptom patterns in women with irritable bowel syndrome (IBS) affect autonomic activity during sleep. Seventy-five women with IBS underwent a polysomnographic sleep study. Twenty-two of the IBS patients were diarrhea-predominant (IBS-D), 33 were constipation-predominant (IBS-C), and 20 patients had alternating symptoms (IBS-A). Autonomic activity was measured by heart rate variability. The IBS-D group had significant vagal withdrawal compared to the IBS-A group during REM and non-REM sleep (P < 0.05). The IBS-D symptom subgroup had significantly (P < 0.05) greater sympathetic dominance during non-REM than IBS-A patients. Lower abdominal pain correlated with sympathetic dominance during sleep in the IBS-D group (r=0.54, P < 0.01). The IBS-D patients were physiologically distinct with regard to autonomic functioning during sleep compared to the alternating patients, but not the constipated patients. Sleep appears to unmask differences in autonomic activity that may distinguish IBS patients.

Entities:  

Mesh:

Year:  2006        PMID: 17080247     DOI: 10.1007/s10620-006-9305-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  23 in total

1.  EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association.

Authors: 
Journal:  Sleep       Date:  1992-04       Impact factor: 5.849

2.  American Gastroenterological Association medical position statement: irritable bowel syndrome.

Authors: 
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 3.  Heart rate variability: origins, methods, and interpretive caveats.

Authors:  G G Berntson; J T Bigger; D L Eckberg; P Grossman; P G Kaufmann; M Malik; H N Nagaraja; S W Porges; J P Saul; P H Stone; M W van der Molen
Journal:  Psychophysiology       Date:  1997-11       Impact factor: 4.016

4.  Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses.

Authors:  S Elsenbruch; W C Orr
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

5.  Heart rate variability during waking and sleep in healthy males and females.

Authors:  S Elsenbruch; M J Harnish; W C Orr
Journal:  Sleep       Date:  1999-12-15       Impact factor: 5.849

6.  Predictors of health care seeking for irritable bowel syndrome: a population based study.

Authors:  N J Talley; P M Boyce; M Jones
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

7.  Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire.

Authors:  W G Thompson; E J Irvine; P Pare; S Ferrazzi; L Rance
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

Review 8.  Stress and the gastrointestinal tract.

Authors:  Vikram Bhatia; Rakesh K Tandon
Journal:  J Gastroenterol Hepatol       Date:  2005-03       Impact factor: 4.029

Review 9.  The treatment of irritable bowel syndrome.

Authors:  W G Thompson
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

Review 10.  Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function.

Authors:  M V Kamath; E L Fallen
Journal:  Crit Rev Biomed Eng       Date:  1993
View more
  9 in total

Review 1.  Interpretation of normalized spectral heart rate variability indices in sleep research: a critical review.

Authors:  Robert L Burr
Journal:  Sleep       Date:  2007-07       Impact factor: 5.849

2.  Sleep measures predict next-day symptoms in women with irritable bowel syndrome.

Authors:  Diana Taibi Buchanan; Kevin Cain; Margaret Heitkemper; Robert Burr; Michael V Vitiello; Jasmine Zia; Monica Jarrett
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

3.  Is childhood abuse or neglect associated with symptom reports and physiological measures in women with irritable bowel syndrome?

Authors:  Margaret M Heitkemper; Kevin C Cain; Robert L Burr; Sang-Eun Jun; Monica E Jarrett
Journal:  Biol Res Nurs       Date:  2010-12-30       Impact factor: 2.522

4.  Evaluation of latent links between irritable bowel syndrome and sleep quality.

Authors:  Massimo Bellini; Angelo Gemignani; Dario Gambaccini; Simona Toti; Danilo Menicucci; Cristina Stasi; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Remo Bedini; Nicola de Bortoli; Santino Marchi
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

5.  Autonomic function at rest and in response to emotional and rectal stimuli in women with irritable bowel syndrome.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  Current insights in to the pathophysiology of Irritable Bowel Syndrome.

Authors:  Theodoros Karantanos; Theofano Markoutsaki; Maria Gazouli; Nicholas P Anagnou; Dimitrios G Karamanolis
Journal:  Gut Pathog       Date:  2010-05-13       Impact factor: 4.181

Review 7.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

8.  Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients.

Authors:  Marcel Mazur; Agata Furgała; Konrad Jabłoński; Tomasz Mach; Piotr Thor
Journal:  Med Sci Monit       Date:  2012-08

9.  The Association of Insomnia, Perceived Immune Functioning, and Irritable Bowel Syndrome Complaints.

Authors:  Stephanie Balikji; Marlou Mackus; Karel A Brookhuis; Johan Garssen; Aletta D Kraneveld; Thomas Roth; Joris C Verster
Journal:  J Clin Med       Date:  2018-08-24       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.